Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,243 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $634.41 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $518.67 | 11 | $0 (2024) |
| Vapotherm Inc | $243.04 | 2 | $0 (2018) |
| ABBVIE INC. | $229.22 | 6 | $0 (2024) |
| Genentech USA, Inc. | $194.44 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $146.54 | 2 | $0 (2023) |
| Amgen Inc. | $145.87 | 2 | $0 (2024) |
| Intuitive Surgical, Inc. | $100.45 | 1 | $0 (2023) |
| Allergan Inc. | $17.23 | 1 | $0 (2019) |
| Cumberland Pharmaceuticals, Inc. | $13.13 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $281.13 | 8 | Amgen Inc. ($145.87) |
| 2023 | $354.93 | 8 | Janssen Pharmaceuticals, Inc ($146.54) |
| 2022 | $249.83 | 2 | AstraZeneca Pharmaceuticals LP ($249.83) |
| 2021 | $124.99 | 1 | AbbVie Inc. ($124.99) |
| 2020 | $133.47 | 2 | PFIZER INC. ($133.47) |
| 2019 | $334.77 | 7 | PFIZER INC. ($305.28) |
| 2018 | $340.30 | 5 | Vapotherm Inc ($243.04) |
| 2017 | $423.58 | 6 | AstraZeneca Pharmaceuticals LP ($151.77) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Rare Disease | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/18/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO, DALVANCE | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/01/2024 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 04/18/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $121.34 | General |
| Category: Cardiology | ||||||
| 12/05/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $100.45 | General |
| Category: SURGERY | ||||||
| 05/24/2023 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/17/2023 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 01/19/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Rare Disease | ||||||
| 10/27/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $125.24 | General |
| Category: Rare Disease | ||||||
| 06/27/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $124.59 | General |
| Category: Rare Disease | ||||||
| 12/07/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/25/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $117.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/05/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/15/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 841 | 865 | $630,991 | $102,962 |
| 2022 | 13 | 1,362 | 1,433 | $911,824 | $162,554 |
| 2021 | 12 | 1,202 | 1,225 | $886,392 | $162,446 |
| 2020 | 6 | 504 | 515 | $479,261 | $76,192 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 262 | 266 | $322,126 | $45,551 | 14.1% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 151 | 154 | $124,124 | $17,522 | 14.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 59 | $26,373 | $7,056 | 26.8% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 47 | 47 | $25,474 | $6,149 | 24.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 74 | 74 | $21,534 | $5,749 | 26.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 26 | 26 | $48,984 | $5,400 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 63 | $12,852 | $4,873 | 37.9% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 68 | 70 | $31,360 | $4,630 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 17 | $5,100 | $1,891 | 37.1% |
| 99234 | Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 16 | $5,440 | $1,455 | 26.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,624 | $1,126 | 31.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 31 | 31 | $3,100 | $1,073 | 34.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 30 | $900.00 | $486.60 | 54.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 356 | 365 | $442,015 | $68,320 | 15.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 266 | 282 | $227,292 | $33,273 | 14.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 263 | 269 | $120,512 | $19,960 | 16.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 96 | 97 | $44,232 | $11,653 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 93 | 93 | $18,972 | $9,341 | 49.2% |
| 99218 | Initial hospital observation care per day, typically 30 minutes | Facility | 2022 | 63 | 63 | $21,546 | $5,596 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 30 | $9,000 | $3,894 | 43.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $8,456 | $3,321 | 39.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 90 | 90 | $9,000 | $3,134 | 34.8% |
| 99235 | Hospital observation or inpatient care admitted and discharged on the same day for moderate severity problem, typically 50 minutes | Facility | 2022 | 11 | 11 | $6,248 | $1,681 | 26.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 37 | 74 | $2,220 | $1,202 | 54.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 18 | 18 | $2,214 | $1,135 | 51.2% |
About Dr. Tadeusz Korszun, MD
Dr. Tadeusz Korszun, MD is a Emergency Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457373896.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tadeusz Korszun, MD has received a total of $2,243 in payments from pharmaceutical and medical device companies, with $281.13 received in 2024. These payments were reported across 39 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,243).
As a Medicare-enrolled provider, Korszun has provided services to 3,909 Medicare beneficiaries, totaling 4,038 services with total Medicare billing of $504,154. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Diagnostic Ultrasound
- Location Manhasset, NY
- Active Since 07/24/2006
- Last Updated 07/29/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1457373896
Products in Payments
- ELIQUIS (Drug) $634.41
- ANDEXXA (Biological) $326.82
- Precision Flow (Device) $243.04
- BRILINTA (Drug) $191.85
- DALVANCE (Drug) $183.57
- XARELTO (Drug) $146.54
- Repatha (Biological) $145.87
- Da Vinci Surgical System (Device) $100.45
- AVYCAZ (Drug) $48.27
- TEFLARO (Drug) $14.61
- CALDOLOR (Drug) $13.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Manhasset
Christopher Raio, Md, MD
Emergency Medicine — Payments: $187,256
Joshua Levine, Md, MD
Emergency Medicine — Payments: $13,958
Laura Patruno, Pa, PA
Emergency Medicine — Payments: $5,785
Jason Zemmel D'amore, Md, MD
Emergency Medicine — Payments: $4,719
David Silver, Md, MD
Emergency Medicine — Payments: $1,153
Dr. Robert Gekle, M.d, M.D
Emergency Medicine — Payments: $1,099